Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.24.10787

Ovarian Cancer in Iranian Women, a Trend Analysis of Mortality and Incidence  

Sharifian, Abdolhamid (Academy of Medical Sciences, Shahid Beheshti University of Medical Sciences)
Pourhoseingholi, Mohamad Amin (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Norouzinia, Mohsen (Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences)
Vahedi, Mohsen (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.24, 2015 , pp. 10787-10790 More about this Journal
Abstract
Background: Ovarian cancer is an important cause of mortality in women. The aim of this study was to evaluate the incidence and mortality rates and trends in the Iranian population and make predictions. Materials and Methods: National incidence from Iranian annual of National Cancer Registration report from 2003 to 2009 and National Death Statistics reported by the Ministry of Health and Medical Education from 1999 to 2004 were included in this study. A time series model (autoregressive) was used to predict the mortality for the years 2007, 2008, 2012 and 2013, with results expressed as annual mortality rates per 100,000. Results: The general mortality rate of ovarian cancer slightly increased during the years under study from 0.01 to 0.75 and reaching plateau according to the prediction model. Mortality was higher for older age. The incidence also increased during the period of the study. Conclusions: Our study indicated remarkable increasing trends in ovarian cancer mortality and incidence. Therefore, attention to high risk groups and setting awareness programs for women are needed to reduce the associated burden in the future.
Keywords
Ovarian cancer; mortality; incidence; trend analysis; Iran;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Akbari ME, Khayamzadeh M (2008). Incidence, mortality and burden of cancers in Iran. In: Akbari ME, editor. Iran cancer report. 1st ed. Tehran: Cancer Res Center, Shahid Beheshti university of medical sciences, 95-125.
2 Arab M, Khayamzadeh M, Mohit M, et al (2009). Survival of ovarian cancer in Iran: 2000-2004. Asian Pac J Cancer Prev, 10, 555-8.
3 Arab M, Khayamzadeh M, Tehranian A, et al (2010). Incidence rate of ovarian cancer in Iran in comparison with developed countries. Indian J Cancer, 47, 322-7.   DOI   ScienceOn
4 Arab M, Noghabaei G, Kazemi SN (2014). Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005. Asian Pac J Cancer Prev, 15, 2461-4.   DOI
5 Bhurgri Y, Shaheen Y, Kayani N, et al (2011). Incidence, trends and morphology of ovarian cancer in Karachi (1995-2002). Asian Pac J Cancer Prev, 12, 1567-71.
6 Burnet NG, Jefferies SJ, Benson RJ, et al (2005). Years of life lost (YLL) from cancer is an important measure of population burden . and should be considered when allocating research funds. Br J Cancer, 92, 241-5.
7 Hirabayashi Y, Marugame T (2009). Comparison of time trends in ovary cancer mortality (1990-2006) in the world, from the WHO Mortality Database. Jpn J Clin Oncol, 39, 860-1.   DOI
8 Hanna L, Adams M (2006). Prevention of ovarian cancer. Best Pract Res Clin Obstet Gynaecol, 20, 339-62.
9 Islamic Repulic of Iran (2009). Ministry of health and medical education. center for disease control & prevention. noncommunicable deputy. cancer office. Iranian An Natl Cancer Registrat Report.
10 Janssen-Heijnen ML, Houterman S, Lemmens VE, et al (2005). Age and co-morbidity in cancer patients: a population-based approach. Cancer Treat Res, 124, 89-107.   DOI
11 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
12 Lope V, Pollan M, Perez-Gomez B, et al (2008). Municipal distribution of ovarian cancer mortality in Spain. BMC Cancer, 8, 258.   DOI
13 Li DP, Du C, Zhang ZM, et al (2014). Breastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies. Asian Pac J Cancer Prev, 15, 4829-37.   DOI
14 Lowe KA, Chia VM, Taylor A, et al (2013). An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol, 130, 107-14.   DOI   ScienceOn
15 Moghimi-Dehkordi B, Safaee A, Vahedi M (2013). Overweight and obesity and related factors in urban Iranian population aged between 20 to 84 years. Ann Med Health Sci Res, 3, 171-6.   DOI
16 Lukanova A, Kaaks R (2005). Endogenous hormones and ovarian cancer: Epidemiology and current hypothesis. Cancer Epidemiol Biomarkers Prev, 14, 98-107.
17 Menon U (2012). Ovarian cancer screening has no effect on disease-specific mortality. Evid Based Med, 17, 47-8.   DOI
18 Marugame T, Hirabayashi Y (2007). Comparison of time trends in ovary cancer incidence (1973-1997) in East Asia, Europe, and the USA, from cancer incidence in five continents vols IV VIII. Jpn J Clin Oncol, 37, 802-3.   DOI
19 Naghavi M (2002). Death report from 18 provinces in Iran. 1st edition. Tehran: Ministry Health.
20 Naghavi M (2003). Death report from 18 provinces in Iran. 1st edition. Tehran: Ministry Health.
21 Naghavi M (2004). Death report from 23 provinces in Iran. 1st edition. Tehran: Ministry Health.
22 National cancer institute (2005). SEER cancer statistics review (1975-2002). Ovarian epithelial cancer (PDG): treatment-health professionals. J National Cancer Institute. Vol 98.
23 Parkin DM, Bray F, Ferlay J, et al (2001). Estimating the world cancer burden: GLOBOCAN 2000. Int J Cancer, 94, 153-6.   DOI
24 Permuth-Weg J, Seliers T (2009). Epidemiology of ovarian cancer. In M. Verme (ed). Methods of Molecular Biology. Cancer Epidemiology, Vol 427; Humana Press.
25 Wang B, Liu SZ, Zheng RS, et al (2014). Time trends of ovarian cancer incidence in China. Asian Pac J Cancer Prev, 15, 191-3.   DOI   ScienceOn
26 Salehi F, Dunfield L, Phillips KP, et al (2008). Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev, 11, 301-21.   DOI   ScienceOn
27 Sant M, Aareleid T, Berrino F, et al (2003). EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol, 14, 61-118.   DOI
28 U.S. Preventive Services Task Force (2013). Screening for ovarian cancer: reaffirmation recommendation statement. Am Fam Physician, 87, Online.
29 Zhou Y, Irwin ML, Risch HA (2011). Pre- and post-diagnosis body mass index, weight change, and ovarian cancer mortality. Gynecol Oncol, 120, 209-13.   DOI